Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sonexa Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01332695
First received: April 7, 2011
Last updated: January 4, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)